Clinical Trials Browser

Phase 2 × INDUSTRY × Histone Deacetylase Inhibitors × Clear all

NCT00792506 2022-02-02

Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma

Phase 2 Terminated

Multiple Myeloma

NCT00185302 2015-12-14

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

Phase 2 Completed

Melanoma